Diabetic Injection Pens Market by Usage (Reusable Pens and Disposable Pens), Product Type (Insulin Pens and Pen Needles), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) - Global Analysis & Forecast 2019-2030

Report ID : 246  |  Published Date : Jun 2020  |  Pages : 170  |  Region : Global  |  Report Code : MD-70





Diabetic Injection Pens Market Overview and Introduction

Diabetic injection pens are reusable or disposable penlike devices used for injecting a desired dose of insulin to regulate blood sugar levels in patients suffering from diabetes. These pens come in two forms disposable and reusable. A disposable insulin pen contains a prefilled cartridge, whereas, reusable pens allow you to replace the insulin cartridge when it is empty. Diabetic insulin pens help in delivering from .5 to 80 units of insulin at a time.

The global diabetic injection pens market is driven by increasing awareness regarding benefits of insulin pen usage, such as self-management. Moreover, increasing cases of diabetics globally and technological advancements are anticipated to further drive the market growth in the forecast period. However, the threat of alternatives to insulin pens and higher cost of these pens is likely to restrain the market to a certain extent.

The global diabetic injection pens market is segmented by usage, product type, distribution channel and region.

Diabetic Injection Pens Market By Usage

 On the basis of usage, the diabetic injection pens market is segmented into reusable pens and disposable pens. Disposable injection pens segment is anticipated to grow at the highest CAGR during the forecast period owing to the advantages of these pens such as ease of use, portability and low possibility of infection.

Diabetic Injection Pens Market By Product Type

 Based on product type, the market can be segmented into insulin pens and pen needles.  Insulin pens segment is anticipated to hold the largest market share in 2018 owing to the rising adoption of insulin pens as they are easy to use and have the ability to deliver smaller doses of insulin accurately.

Diabetic Injection Pens Market By Distribution Channel

Similarly, in terms of distribution channel the diabetic injection pens market can be segmented into hospital pharmacy, retail pharmacy and online pharmacy. Hospitals segment held the largest market share owing to the rising adoption of diabetic injection pens in hospitals.

Diabetic Injection Pens Market By Region

The global diabetic injection pen market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of diabetic injection pens, followed by Europe and Asia Pacific. North America will continue to dominate the global diabetic injection pens market in the forecast period owing to factors such as increasing number of  diabetic patients, the focus of prominent players in the region to develop and launch diabetic injection pens and increasing number of awareness programs in this region.

Diabetic Injection Pens Market Prominent Players

Some of the prominent players in the global diabetic injection pens market include Novo Nordisk A/S, AstraZeneca, Eli Lilly and Company, BD, Sanofi, Owen Mumford Ltd., Shanghai Benemae Pharmaceutical Corporation, Jiangsu Delfu medical device Co.,Ltd, F. Hoffmann-La Roche Ltd & Biocon among others.